SEC-sourced researchBeta

MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.

US markets

Data passport

CIK: 0001823239
Exchange: Nasdaq
Business activity: — · SIC 2834
Financial inputs: 6/6
Filing date: Oct 1, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

MRVI · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	288,945,000.0000	Feb 26, 2026
December 2024	259,185,000.0000	Feb 26, 2026
December 2025	185,743,000.0000	Feb 26, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	185,743,000.0000	-130,773,000.0000	-57,573,000.0000	770,577,000.0000	397,866,000.0000	Feb 26, 2026
December 2024	259,185,000.0000	-144,846,000.0000	7,465,000.0000	1,008,244,000.0000	431,035,000.0000	Feb 26, 2026
December 2023	288,945,000.0000	-119,029,000.0000	126,224,000.0000	—	—	Feb 26, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$185.74M	December 2025	Feb 26, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$259.19M	December 2024	Feb 26, 2026	10-K
Net incomeNetIncomeLoss	-$130.77M	December 2025	Feb 26, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$57.57M	December 2025	Feb 26, 2026	10-K
Total assetsAssets	$770.58M	December 2025	Feb 26, 2026	10-K
Total liabilitiesLiabilities	$397.87M	December 2025	Feb 26, 2026	10-K

New filings

Explore methodology ↗